Abstract:BackgroundFluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) has been widely used for the diagnosis of pancreatic cancer. Because autoimmune pancreatitis is easily misdiagnosed as pancreatic cancer and can be tested for by FDG-PET analysis based on the presence of suspected pancreatic cancer, we attempted to clarify the differences in FDG-PET findings between the two conditions.MethodsWe compared FDG-PET findings between 15 patients with autoimmune pancreatitis and 26 patients with pancreatic cancer. The findings were evaluated visually or semiquantitatively using the maximum standardized uptake value and the accumulation pattern of FDG.ResultsFDG uptake was found in all 15 patients with autoimmune pancreatitis, whereas it was found in 19 of 26 patients (73.1%) with pancreatic cancer. An accumulation pattern characterized by nodular shapes was significantly more frequent in pancreatic cancer, whereas a longitudinal shape indicated autoimmune pancreatitis. Heterogeneous accumulation was found in almost all cases of autoimmune pancreatitis, whereas homogeneous accumulation was found in pancreatic cancer. Significantly more cases of pancreatic cancer showed solitary localization, whereas multiple localization in the pancreas favored the presence of autoimmune pancreatitis. FDG uptake by the hilar lymph node was significantly more frequent in autoimmune pancreatitis than in pancreatic cancer, and uptake by the lachrymal gland, salivary gland, biliary duct, retroperitoneal space, and prostate were seen only in autoimmune pancreatitis.ConclusionsFDG-PET is a useful tool for differentiating autoimmune pancreatitis from suspected pancreatic cancer, if the accumulation pattern and extrapancreatic involvement are considered. IgG4 measurement and other current image tests can further confirm the diagnosis.

Increased FDG Uptake of Heterotopic Pancreatitis in the Stomach.

Increased F-18-Fdg Uptake of Heterotopic Pancreatitis in the Small Intestine: A Care-Compliant Case Report

FDG PET/CT in Pancreatic Ductal Adenocarcinoma Arising From a Heterotopic Pancreas of the Pylorus

F-18 FDG Hypermetabolism in Mass-Forming Focal Pancreatitis and Old Hepatic Schistosomiasis with Granulomatous Inflammation Misdiagnosed by PET/CT Imaging.

Adenocarcinoma Developing from Gastric Heterotopic Pancreas: a Case Report and Short Review

Hypermetabolic lesions of the pancreas on FDG PET/CT

Serous Cystadenoma of the Pancreas Showing Increased Uptake on Ga-68-FAPI PET/CT

18F-FDG PET/CT imaging of hepatic ectopic pancreas: a case report

Heterotopic pancreas in the gallbladder: A case report

Imaging Intratumoral Heterogeneity of Diffuse Pancreatic Neuroendocrine Tumor With Multitracer PET/CT

Serous Cystadenoma of the Pancreas Showing Increased Uptake on 68Ga-FAPI PET/CT

Serous Cystadenoma of the Pancreas Showing Increased Uptake on 68 Ga-FAPI PET/CT.

Insight into gastrointestinal heterotopic pancreas: imaging evaluation and differential diagnosis

Mesenteric Heterotopic Pancreas in a Pediatric Patient: A Case Report and Review of Literature

Autoimmune Pancreatitis With F-18 Fluoro-2-deoxy-D-Glucose PET Findings

Heterotopic pancreas - An expert in hide and seek

Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography

68Ga-FAPI PET/CT Detected Non–FDG-Avid Gastric Stromal Tumor

CT Findings About Heterotopic Pancreas in the Alimentary Tract

The Application of [68Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models

68Ga-FAPI PET/CT Depicted the Fibrosis of Ischemic Colitis